美国FDA生物制品紫皮书数据库
(U.S. FDA Purple Book: Database of Licensed Biological Products)
商品名 申请号 产品号 BLA类型 非专利名称 剂型 给药途径 规格/剂量 产品形式 批准日期 申请人 市场状态 许可证状态 参考产品非专利名称 参考产品专利名称
Cosentyx 125504 003 351(a) secukinumab For Injection Subcutaneous 150MG Single-Dose Vial 2015/01/21 Novartis Pharmaceuticals Corporation Disc Licensed N/A N/A
Keytruda 125514 002 351(a) pembrolizumab Injection Intravenous 100MG/4ML (25MG/ML) Single-Dose Vial 2015/01/15 Merck Sharp & Dohme LLC Rx Licensed N/A N/A
Neulasta Onpro 125031 002 351(a) pegfilgrastim Injection Subcutaneous 6MG/0.6ML Pre-Filled Syringe 2014/12/23 Amgen Inc. Rx Licensed N/A N/A
Opdivo 125554 001 351(a) nivolumab Injection Intravenous 40MG/4ML (10MG/ML) Single-Dose Vial 2014/12/22 Bristol-Myers Squibb Company Rx Licensed N/A N/A
Opdivo 125554 002 351(a) nivolumab Injection Intravenous 100MG/10ML (10MG/ML) Single-Dose Vial 2014/12/22 Bristol-Myers Squibb Company Rx Licensed N/A N/A
Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent 103914 008 351(a) Influenza Virus Vaccine Injection Intradermal 36UG/.5ML Pre-Filled Syringe 2014/12/11 Sanofi Pasteur Inc. Disc Licensed N/A
Gardasil 9 125508 001 351(a) Human Papillomavirus 9-valent Vaccine, Recombinant Injection Intramuscular 0.5ML Pre-Filled Syringe 2014/12/10 Merck Sharp & Dohme LLC Rx Licensed N/A
Gardasil 9 125508 002 351(a) Human Papillomavirus 9-valent Vaccine, Recombinant Injection Intramuscular 0.5ML Single-dose vial 2014/12/10 Merck Sharp & Dohme LLC Rx Licensed N/A
Blincyto 125557 001 351(a) blinatumomab For Injection Intravenous 35MCG Single-Dose Vial 2014/12/03 Amgen Inc. Rx Licensed N/A N/A
Lemtrada 103948 002 351(a) alemtuzumab Injection Intravenous 12MG/1.2ML (10MG/ML) Single-Dose Vial 2014/11/14 Genzyme Corporation Rx Licensed N/A N/A
Trumenba 125549 001 351(a) Meningococcal Group B Vaccine Injection Intramuscular 0.5ML Pre-Filled Syringe 2014/10/29 Wyeth Pharmaceuticals LLC Rx Licensed N/A
Obizur 125512 001 351(a) Antihemophilic Factor (Recombinant), Porcine Sequence For Injection Intravenous 500U Single-Dose Vial 2014/10/23 Takeda Pharmaceuticals U.S.A., Inc. Rx Licensed N/A
Varizig 125430 002 351(a) Varicella Zoster Immune Globulin (Human) Injection Intramuscular 125IU Single-Dose Vial 2014/09/29 Kamada Ltd. Rx Licensed N/A
Humira 125057 005 351(a) adalimumab Injection Subcutaneous 10MG/0.2ML Pre-Filled Syringe 2014/09/23 AbbVie Inc. Disc* Licensed N/A N/A
Trulicity 125469 001 351(a) dulaglutide Injection Subcutaneous 0.75MG/0.5ML Autoinjector 2014/09/18 Eli Lilly and Company Rx Licensed N/A N/A
Trulicity 125469 002 351(a) dulaglutide Injection Subcutaneous 1.5MG/0.5ML Autoinjector 2014/09/18 Eli Lilly and Company Rx Licensed N/A N/A
Trulicity 125469 003 351(a) dulaglutide Injection Subcutaneous 0.75MG/0.5ML Pre-Filled Syringe 2014/09/18 Eli Lilly and Company Disc Licensed N/A N/A
Trulicity 125469 004 351(a) dulaglutide Injection Subcutaneous 1.5MG/0.5ML Pre-Filled Syringe 2014/09/18 Eli Lilly and Company Disc Licensed N/A N/A
Hyqvia 125402 001 351(a) Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase Injection Subcutaneous 0.1 Bottle 2014/09/12 Takeda Pharmaceuticals U.S.A., Inc. Rx Licensed N/A
Keytruda 125514 001 351(a) pembrolizumab For Injection Intravenous 50MG Single-Dose Vial 2014/09/04 Merck Sharp & Dohme LLC Disc Licensed N/A N/A
当前数据更新日期:2026年02月10日,更多信息请点击此处查询美国FDA药品数据库

数据库说明:

©2006-2026 DrugFuture->U.S. FDA Purple Book